Zantac Lawsuit

® Quick Summary

In April 2020, the FDA requested removal of Zantac and other ranitidine medications from the market. This removal was sparked by new research indicating the presence of NDMA, a harmful probable carcinogen, in medications containing ranitidine. If you or a loved one developed certain cancers after taking Zantac or another drug containing ranitidine, you may be entitled to compensation. Contact Sokolove Law today for a free case review.

New Zantac Developments

As of April 1, 2020, the FDA has requested that all manufacturers of Zantac or other ranitidine medications remove these drugs from the market immediately. This includes both prescription and over-the-counter (OTC) medications.

Ranitidine can form a probable human carcinogen called NDMA when stored in higher than room temperatures. Since Zantac may be stored at unreliable temperatures, it may become unsafe to consume.

In the summer of 2019, the FDA first became aware of independent lab testing that found the ranitidine molecule may be unstable and form NDMA when ingested. In light of this information, ranitidine products may not be available for new or existing prescriptions or OTC use in the U.S.

Zantac or ranitidine users who have been diagnosed with the cancers listed below may be able to file a Zantac lawsuit.

  • Bladder Cancer
  • Kidney Cancer
  • Breast Cancer
  • Pancreatic Cancer
  • Colon Cancer
  • Stomach Cancer
  • Testicular Cancer

What Is Zantac?

Zantac is a prescription and over-the-counter histamine-2 receptor antagonist, meaning the drug works to decrease the amount of acid created by the stomach.

Zantac’s active ingredient, ranitidine, has been approved by the U.S. Food and Drug Administration (FDA) to prevent and/or relieve heartburn caused by sour stomach and acid indigestion.

In addition to heartburn relief, ranitidine is also approved to:

  • Treat and prevent stomach ulcers
  • Treat and prevent ulcers in the intestines
  • Treat gastroesophageal reflux disease (GERD)

While Zantac may provide heartburn relief, the acid-reducing pills may come with an increased risk of various types of cancer.

New research indicates that the presence of NDMA in drugs like Zantac was the result of an “inherent instability” of the ranitidine molecule. In other words, ranitidine has the potential to form millions of nanograms of cancer-causing NDMA at higher temperatures, or in the human body when ingested.

N-nitrosodimethylamine (NDMA) is a known probable carcinogen and is used as an industrial chemical in gasoline, rocket fuel, and other petroleum products.

Why File a Zantac Lawsuit

Recent Zantac lawsuits allege that the drug’s manufacturer, Sanofi, failed to warn users that the drug’s main ingredient is unstable — and may form NDMA.

Lawsuits are being filed across the country, and Zantac law firms are suing Sanofi U.S. Services Inc. for fraud, products liability, and negligence.

If you currently use Zantac or another ranitidine medication — or have used it in the past — and have developed certain cancers, you may be able to file a lawsuit against the drug makers.

Reach out to the Zantac lawyers at Sokolove Law to learn more and get a free case review.

Zantac Injuries

The Zantac lawyers at Sokolove Law are currently reviewing cases involving cancer associated with Zantac and other ranitidine prescription and over-the-counter drugs.

Some cancer diagnoses may be the result of exposure to NDMA, which is classified by the World Health Organization (WHO) as “clearly carcinogenic,” or cancer-causing.

NDMA exposure from Zantac may be linked to:

  • Bladder cancer
  • Breast Cancer
  • Colon cancer
  • Kidney cancer
  • Pancreatic cancer
  • Stomach cancer
  • Testicular cancer

Get Legal Help with a Zantac Lawsuit

If you or a loved one are a present or past user of Zantac, or another ranitidine medication, and have now been diagnosed with the cancers listed above, you may wish to pursue a Zantac lawsuit.

Zantac settlements or verdicts may result in financial compensation to pay for medical treatments, lost wages, pain and suffering, and other expenses.

The Zantac attorneys at Sokolove Law know that good health is priceless — but users who have fallen victim to these dangerous drugs’ consequences may be able to seek financial compensation with the help of a Zantac law firm.

Take the first step: Start a free case review today.

Author:Sokolove Law Team
Sokolove Law Team

Contributing Authors

The Sokolove Law Content Team is made up of writers, editors, and journalists. We work with case managers and attorneys to keep site information up to date and accurate. Our site has a wealth of resources available for victims of wrongdoing and their families.

Last modified: September 10, 2020

View 6 Sources
  1. Carcinogen in Zantac and Generics Triggers FDA, EU Probes, Bloomberg News, 9/13/19. https://www.bloomberg.com/news/articles/2019-09-13/europe-will-review-carcinogen-content-of-stomach-acid-treatments

  2. Guidelines for Drinking-Water Quality, 3rd edition including 1st and 2nd addenda, 2008. https://www.who.int/water_sanitation_health/dwq/chemicals/ndmasummary_2ndadd.pdf

  3. Hagens Berman: National Class Action Lawsuit Accuses Sanofi of Concealing Zantac Cancer Risk, 9/13/19. https://finance.yahoo.com/news/hagens-berman-national-class-action-011200403.html

  4. Hagens Berman Files Second Class-Action Lawsuit Regarding Concealed Zantac Cancer Risk, 9/20/19. https://www.hbsslaw.com/cases/zantac-ranitidine-antacid-drug/pressrelease/zantac-ranitidine-antacid-drug-hagens-berman-files-second-class-action-lawsuit-regarding-concealed-zantac-cancer-risk

  5. Hagens Berman: Law Firm Taking on Drug Makers in Zantac Class Action Condemns FDA’s “Reckless” Cover-up of Ranitidine Carcinogen, Press Release dated 10/3/19. https://www.businesswire.com/news/home/20191003005876/en/Hagens-Berman-Law-Firm-Drug-Makers-Zantac

  6. Mary Santorella, et al. v. Sanofi-Aventis U.S. LLC, et al. USDC District of New Jersey, 3:19-cv-18146.